MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1055/a-2640-0775

Медицинская библиотека · The International journal of angiology : official publication of the International College of Angiology, Inc · 2025

Investigation of the Survival Time of Patients Who Underwent Endovascular Treatment Due to Type 3 Aortic Dissection and Factors Affecting This Duration.

Işık Mehmet, Günerhan Yalçın, Tanyeli Ömer, Yıldırım Serkan, Demiray Ali

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

This study aimed to analyze the survival time of patients who underwent thoracic endovascular aortic replacement (TEVAR) due to acute type 3 aortic dissection and to investigate comorbid conditions and dissection characteristics that affect survival time.

MATERIALS AND

METHODS

Between 2013 and 2023, 94 patients who underwent TEVAR for type 3 dissection were retrospectively investigated. Survival time and factors affecting this time (comorbidity and dissection characteristics) were analyzed.

RESULTS

The most common comorbidities were hypertension (88%). There was no significant difference between the demographic data of surviving and deceased patients. During the follow-up period, 57% of the patients survived, and 43% of the patients died. The mean survival time after TEVAR was 20.1 (0-108) months among patients who died and 47.7 (2-120) months for patients who lived. The mean number of comorbidities was 2.13 in patients who died and 2.25 in patients who survived. Survival distribution according to the type of interventional procedure was 50% for partial closure of the subclavian artery, 38.1% for complete closure, and 66.2% for closure starting from the distal subclavian artery ( p  = 0.06). Survival rate was significantly higher in patients who underwent reintervention ( p  = 0.005). Mortality was 9.5% in the early period, 25.5% in the first year, 29.7% in the second year, 34% in the third year, and 39.3% in the first 5 years.

CONCLUSION

In our study, the survival rate was higher in patients who were followed regularly, and reintervention was applied when necessary. Therefore, we believe that undetected or untreated complications after TEVAR, rather than comorbid conditions, negatively affect survival more.

Для цитирования: Işık Mehmet, Günerhan Yalçın, Tanyeli Ömer, Yıldırım Serkan, Demiray Ali. Investigation of the Survival Time of Patients Who Underwent Endovascular Treatment Due to Type 3 Aortic Dissection and Factors Affecting This Duration.. The International journal of angiology : official publication of the International College of Angiology, Inc. 2025. DOI: 10.1055/a-2640-0775.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.